• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

分析预防糖皮质激素性骨质疏松症的质量改进措施。

Analysis of quality improvement efforts in preventing glucocorticoid-induced osteoporosis.

机构信息

Rheumatology Program, Division of Immunology, Boston Children׳s Hospital, Boston, MA; Center for Clinical Excellence, Brigham and Women׳s Hospital, 1620 Tremont St, 2nd Floor, Boston, MA 02120.

Division of Rheumatology, Immunology and Allergy, Department of Medicine, Brigham and Women׳s Hospital, Boston, MA; Division of Pharmacoepidemiology, Brigham and Women׳s Hospital, Boston, MA.

出版信息

Semin Arthritis Rheum. 2015 Apr;44(5):483-488. doi: 10.1016/j.semarthrit.2014.09.011.

DOI:10.1016/j.semarthrit.2014.09.011
PMID:25845488
Abstract

OBJECTIVE

To report and analyze quality improvement (QI) efforts that are aimed at increasing adherence to preventive guidelines for glucocorticoid-induced osteoporosis (GIOP).

METHODS

We performed a PubMed literature search for full-length articles in English between 1966 and 2013, describing approaches for improving the quality of GIOP care. We reviewed articles using a structured approach and abstracted information on the patient population, study design, QI intervention, and primary outcome measures. A descriptive analysis was then performed.

RESULTS

Literature search identified 661 articles; 38 were screened by abstract, 10 were identified for full review, and 7 were included. Two non-randomized, uncontrolled studies of system changes showed significant improvements in GIOP prevention: one increased concomitant prescriptions of glucocorticoids and calcium (37-49%, p < 0.0001) and vitamin D (38-53%, p < 0.0001) using a computerized order entry system; another used a dedicated clinical team to increase vitamin D levels from 19.5 to 29.4 (p = 0.001) and improve GIOP-related habits. Five articles described education-based interventions, including 3 randomized controlled trials (RCTs). Two non-significant RCTs focused on physicians, but one directed towards pharmacists and patients did increase calcium supplementation in the intervention vs. control arm (55.7% vs. 31.6%, p < 0.05). Two other non-randomized educational interventions did not show benefits. Comparison of articles was limited by the heterogeneity of the intervention methods and outcome measures used.

CONCLUSION

None of the interventions produced robust changes, with overall adherence to GIOP guidelines remaining low. System-based interventions appeared more effective than education-based interventions, but a diverse array of factors likely needs to be addressed, requiring more randomized controlled trials and greater standardization of outcome measures.

摘要

目的

报告和分析旨在提高糖皮质激素性骨质疏松症(GIOP)预防指南依从性的质量改进(QI)工作。

方法

我们在 1966 年至 2013 年间对英文全文文献进行了 PubMed 文献检索,描述了改善 GIOP 护理质量的方法。我们使用结构化方法对文章进行了审查,并摘录了患者人群、研究设计、QI 干预和主要结局指标的信息。然后进行了描述性分析。

结果

文献检索确定了 661 篇文章;通过摘要筛选了 38 篇,确定了 10 篇进行全文审查,其中 7 篇被纳入。两项关于系统变化的非随机、非对照研究显示,GIOP 预防显著改善:一项通过计算机订单录入系统增加了同时开具糖皮质激素和钙(37-49%,p < 0.0001)和维生素 D(38-53%,p < 0.0001)的处方;另一项使用专门的临床团队将维生素 D 水平从 19.5 提高到 29.4(p = 0.001),并改善了与 GIOP 相关的习惯。五篇文章描述了基于教育的干预措施,包括三项随机对照试验(RCT)。两项非显著性 RCT 侧重于医生,但一项针对药剂师和患者的 RCT 确实增加了干预组与对照组的钙补充剂(55.7%比 31.6%,p < 0.05)。另外两项非随机教育干预措施没有显示出益处。由于干预方法和使用的结局指标的异质性,文章的比较受到限制。

结论

没有一项干预措施产生了显著的变化,GIOP 指南的总体依从率仍然很低。基于系统的干预措施似乎比基于教育的干预措施更有效,但可能需要解决更多的因素,需要更多的随机对照试验和更标准化的结局指标。

相似文献

1
Analysis of quality improvement efforts in preventing glucocorticoid-induced osteoporosis.分析预防糖皮质激素性骨质疏松症的质量改进措施。
Semin Arthritis Rheum. 2015 Apr;44(5):483-488. doi: 10.1016/j.semarthrit.2014.09.011.
2
Effects of quality indicator monitoring for glucocorticoid-induced osteoporosis and trends of drug treatment in a Japanese hospital.日本一家医院糖皮质激素性骨质疏松症质量指标监测的效果及药物治疗趋势
Int J Rheum Dis. 2018 May;21(5):975-981. doi: 10.1111/1756-185X.13310.
3
Barriers in the management of glucocorticoid-induced osteoporosis.糖皮质激素性骨质疏松症管理中的障碍。
Arthritis Rheum. 2007 Feb 15;57(1):140-6. doi: 10.1002/art.22462.
4
Glucocorticoid-induced osteoporosis preventive care in rheumatology patients.风湿科患者糖皮质激素性骨质疏松的预防护理。
Arch Osteoporos. 2019 Feb 5;14(1):16. doi: 10.1007/s11657-019-0570-9.
5
Increase in prophylaxis of glucocorticoid-induced osteoporosis by pharmacist feedback: a randomised controlled trial.通过药师反馈增加糖皮质激素性骨质疏松症的预防:一项随机对照试验。
Osteoporos Int. 2014 Jan;25(1):385-92. doi: 10.1007/s00198-013-2562-8. Epub 2013 Nov 13.
6
Population-based trends in osteoporosis management after new initiations of long-term systemic glucocorticoids (1998-2008).基于人群的长期全身糖皮质激素新使用者骨质疏松管理趋势(1998-2008 年)。
J Clin Endocrinol Metab. 2012 Apr;97(4):1236-42. doi: 10.1210/jc.2011-2645. Epub 2012 Feb 1.
7
The disconnect between better quality of glucocorticoid-induced osteoporosis preventive care and better outcomes: a population-based cohort study.更好的糖皮质激素诱导性骨质疏松预防护理质量与更好结局之间的脱节:一项基于人群的队列研究。
J Rheumatol. 2013 Oct;40(10):1736-41. doi: 10.3899/jrheum.130041. Epub 2013 Jul 1.
8
Challenges in improving the quality of osteoporosis care for long-term glucocorticoid users: a prospective randomized trial.改善长期使用糖皮质激素患者骨质疏松症护理质量面临的挑战:一项前瞻性随机试验
Arch Intern Med. 2007 Mar 26;167(6):591-6. doi: 10.1001/archinte.167.6.591.
9
An Internet-based Controlled Trial Aimed to Improve Osteoporosis Prevention among Chronic Glucocorticoid Users.一项旨在改善慢性糖皮质激素使用者骨质疏松症预防情况的基于互联网的对照试验。
J Rheumatol. 2015 Aug;42(8):1478-83. doi: 10.3899/jrheum.141238. Epub 2015 Jul 1.
10
Quality assurance study of the use of preventative therapies in glucocorticoid-induced osteoporosis in early inflammatory arthritis: results from the CATCH cohort.糖皮质激素诱导的早期炎症性关节炎性骨质疏松症预防性治疗的质量保证研究:CATCH 队列的结果。
Rheumatology (Oxford). 2012 Sep;51(9):1662-9. doi: 10.1093/rheumatology/kes079. Epub 2012 Apr 25.

引用本文的文献

1
Evaluation of Steroid-Induced Osteoporosis Prevention Using Tracing Reports in Collaboration between Hospitals and Community Pharmacists.利用医院与社区药剂师合作的追踪报告评估类固醇诱导的骨质疏松症预防情况。
Pharmacy (Basel). 2024 May 15;12(3):80. doi: 10.3390/pharmacy12030080.
2
Development and Comparison of Treatment Decision Tools for Glucocorticoid-Induced Osteoporosis.糖皮质激素性骨质疏松症治疗决策工具的开发与比较
Diagnostics (Basel). 2024 Feb 19;14(4):452. doi: 10.3390/diagnostics14040452.
3
Prevention and Treatment of Glucocorticoid-Induced Osteoporosis in Adults: Consensus Recommendations From the Belgian Bone Club.
成人糖皮质激素性骨质疏松症的预防和治疗:来自比利时骨俱乐部的共识建议。
Front Endocrinol (Lausanne). 2022 Jun 9;13:908727. doi: 10.3389/fendo.2022.908727. eCollection 2022.
4
Preventive effects of on glucocorticoid-induced osteoporosis in rats.[具体物质]对大鼠糖皮质激素性骨质疏松的预防作用
Exp Ther Med. 2017 Sep;14(3):2445-2460. doi: 10.3892/etm.2017.4802. Epub 2017 Jul 18.
5
Behavior change interventions and policies influencing primary healthcare professionals' practice-an overview of reviews.影响基层医疗保健专业人员实践的行为改变干预措施与政策——综述概述
Implement Sci. 2017 Jan 5;12(1):3. doi: 10.1186/s13012-016-0538-8.
6
Glucocorticoid-induced osteoporosis: pathophysiological role of GH/IGF-I and PTH/VITAMIN D axes, treatment options and guidelines.糖皮质激素性骨质疏松症:GH/IGF-I 和 PTH/VITAMIN D 轴的病理生理学作用、治疗选择和指南。
Endocrine. 2016 Dec;54(3):603-611. doi: 10.1007/s12020-016-1146-8. Epub 2016 Oct 20.